GR72769B - - Google Patents
Info
- Publication number
- GR72769B GR72769B GR64497A GR810164497A GR72769B GR 72769 B GR72769 B GR 72769B GR 64497 A GR64497 A GR 64497A GR 810164497 A GR810164497 A GR 810164497A GR 72769 B GR72769 B GR 72769B
- Authority
- GR
- Greece
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13537380A | 1980-03-31 | 1980-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR72769B true GR72769B (tr) | 1983-12-02 |
Family
ID=22467813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR64497A GR72769B (tr) | 1980-03-31 | 1981-03-26 |
Country Status (30)
Country | Link |
---|---|
JP (1) | JPS56152415A (tr) |
KR (1) | KR860000841B1 (tr) |
AR (1) | AR225500A1 (tr) |
AT (1) | AT370996B (tr) |
AU (1) | AU541056B2 (tr) |
BE (1) | BE888209A (tr) |
CA (1) | CA1162479A (tr) |
CH (1) | CH647481A5 (tr) |
CS (1) | CS246051B2 (tr) |
DD (1) | DD157762A5 (tr) |
DE (1) | DE3112272A1 (tr) |
DK (1) | DK158564C (tr) |
ES (1) | ES8206545A1 (tr) |
FI (1) | FI70670C (tr) |
FR (1) | FR2480605A1 (tr) |
GB (1) | GB2074028B (tr) |
GR (1) | GR72769B (tr) |
HU (1) | HU183379B (tr) |
IE (1) | IE51070B1 (tr) |
IL (1) | IL62517A (tr) |
IT (1) | IT1170838B (tr) |
LU (1) | LU83270A1 (tr) |
NL (1) | NL8101531A (tr) |
NO (1) | NO156675C (tr) |
NZ (1) | NZ196519A (tr) |
PH (1) | PH17152A (tr) |
PT (1) | PT72774B (tr) |
SE (1) | SE455045B (tr) |
SU (1) | SU1056893A3 (tr) |
ZA (1) | ZA812084B (tr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1153974B (it) * | 1982-09-23 | 1987-01-21 | Erba Farmitalia | Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento |
NL8303657A (nl) * | 1983-10-24 | 1985-05-17 | Pharmachemie Bv | Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan. |
FI895340A0 (fi) * | 1988-11-14 | 1989-11-09 | Bristol Myers Squibb Co | Hypertonisk cisplatin-loesning. |
ES2208946T3 (es) * | 1996-08-23 | 2004-06-16 | Sequus Pharmaceuticals, Inc. | Liposomas que contienen un compuesto de cisplatino. |
AUPQ641100A0 (en) | 2000-03-23 | 2000-04-15 | Australia Nuclear Science & Technology Organisation | Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents |
JP4445304B2 (ja) | 2004-03-26 | 2010-04-07 | オンキヨー株式会社 | スイッチングアンプ |
US8852566B2 (en) * | 2009-03-26 | 2014-10-07 | Warsaw Orthopedic, Inc. | Compositions and methods for preferential distribution of active agents to injury sites |
ES2928931T3 (es) | 2018-03-29 | 2022-11-23 | Project Pharmaceutics Gmbh | Formulación farmacéutica líquida |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4177263A (en) * | 1972-02-28 | 1979-12-04 | Research Corporation | Anti-animal tumor method |
SE445172B (sv) * | 1978-05-30 | 1986-06-09 | Bristol Myers Co | Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform |
-
1981
- 1981-03-06 CA CA000372499A patent/CA1162479A/en not_active Expired
- 1981-03-06 AU AU68166/81A patent/AU541056B2/en not_active Ceased
- 1981-03-17 NZ NZ196519A patent/NZ196519A/xx unknown
- 1981-03-24 IT IT48090/81A patent/IT1170838B/it active
- 1981-03-24 FR FR8105848A patent/FR2480605A1/fr active Granted
- 1981-03-25 CH CH2023/81A patent/CH647481A5/fr not_active IP Right Cessation
- 1981-03-26 GR GR64497A patent/GR72769B/el unknown
- 1981-03-26 FI FI810934A patent/FI70670C/fi not_active IP Right Cessation
- 1981-03-27 PH PH25435A patent/PH17152A/en unknown
- 1981-03-27 DE DE19813112272 patent/DE3112272A1/de active Granted
- 1981-03-27 SE SE8101990A patent/SE455045B/sv not_active IP Right Cessation
- 1981-03-27 NL NL8101531A patent/NL8101531A/nl not_active Application Discontinuation
- 1981-03-27 ZA ZA00812084A patent/ZA812084B/xx unknown
- 1981-03-28 KR KR1019810001029A patent/KR860000841B1/ko active
- 1981-03-30 GB GB8109926A patent/GB2074028B/en not_active Expired
- 1981-03-30 SU SU813265697A patent/SU1056893A3/ru active
- 1981-03-30 IE IE715/81A patent/IE51070B1/en not_active IP Right Cessation
- 1981-03-30 HU HU81811A patent/HU183379B/hu not_active IP Right Cessation
- 1981-03-30 PT PT72774A patent/PT72774B/pt not_active IP Right Cessation
- 1981-03-30 IL IL62517A patent/IL62517A/xx unknown
- 1981-03-30 AR AR284799A patent/AR225500A1/es active
- 1981-03-30 ES ES500869A patent/ES8206545A1/es not_active Expired
- 1981-03-30 DK DK144281A patent/DK158564C/da not_active IP Right Cessation
- 1981-03-30 JP JP4569081A patent/JPS56152415A/ja active Granted
- 1981-03-30 NO NO811081A patent/NO156675C/no unknown
- 1981-03-31 DD DD81228776A patent/DD157762A5/de not_active IP Right Cessation
- 1981-03-31 CS CS812390A patent/CS246051B2/cs unknown
- 1981-03-31 BE BE0/204323A patent/BE888209A/fr not_active IP Right Cessation
- 1981-03-31 LU LU83270A patent/LU83270A1/fr unknown
- 1981-03-31 AT AT0150481A patent/AT370996B/de not_active IP Right Cessation